Robin Carhart - Harris

Robin is the Head of the Centre for Psychedelic Research, in the Department of Brain Sciences at Imperial College London, where he has designed a number of functional brain imaging studies with psilocybin (magic mushrooms), LSD, MDMA (ecstasy) and DMT (ayahuasca), plus clinical trials of psilocybin for treatment-resistant depression. His scientific contributions to psychedelic-assisted therapy could play a significant role in the future of psychedelics for mental health care.

Robin states that scientific investigation into the therapeutic potential of psychedelics is vital for combating the mental health crisis. As a partner with the center, scientific research shows that the Synthesis experience was found to significantly reduce symptoms of anxiety and depression, improve sense of wellbeing and emotional stability, and increase connection to self, others and nature. Legal, professionally-organised retreats like Synthesis can be a safe way for people to experience the transformational potential of psychedelics, and they can also be a great source of data for research, helping to further advance the field. Robin is excited to continue working alongside Synthesis to provide high-quality services and meaningful scientific research for the psychedelic community.